David Hale - Guerbet S MD CEO
| GBT Stock | EUR 26.40 0.25 0.96% |
Insider
David Hale is MD CEO of Guerbet S A
| Age | 55 |
| Phone | 33 1 45 91 50 00 |
| Web | https://www.guerbet.com |
David Hale Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Hale against Guerbet S stock is an integral part of due diligence when investing in Guerbet S. David Hale insider activity provides valuable insight into whether Guerbet S is net buyers or sellers over its current business cycle. Note, Guerbet S insiders must abide by specific rules, including filing SEC forms every time they buy or sell Guerbet S'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Hale over six months ago Acquisition by David Hale of 10000 shares of Dermata Therapeutics at 0.6099 subject to Rule 16b-3 |
Guerbet S Management Efficiency
The company has return on total asset (ROA) of 0.0137 % which means that it generated a profit of $0.0137 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0308 %, meaning that it generated $0.0308 on every $100 dollars invested by stockholders. Guerbet S's management efficiency ratios could be used to measure how well Guerbet S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Christian Karst | Virbac SA | 64 | |
| Marine Henin | Bonduelle SCA | N/A | |
| Fabrice Rey | Boiron SA | N/A | |
| Celine Barral | Bonduelle SCA | N/A | |
| Marc Bistuer | Virbac SA | N/A | |
| Jean Siret | LNA Sante SA | 71 | |
| Christine Place | Boiron SA | N/A | |
| Guillaume Debrosse | Bonduelle SCA | N/A | |
| Yan MD | Ipsen SA | 56 | |
| Sandrine Brunel | Virbac SA | N/A | |
| Valrie LorentzPoinsot | Boiron SA | 54 | |
| JeanChristophe Bayssat | Boiron SA | 60 | |
| Paul Sekhri | Ipsen SA | 61 | |
| Philippe LopesFernandes | Ipsen SA | N/A | |
| Nathalie Pollet | Virbac SA | N/A | |
| Andrea Montagna | Bonduelle SCA | N/A | |
| Sophie Favini | Virbac SA | N/A | |
| Bertrand Havrileck | Virbac SA | N/A | |
| Manuela Rodrguez | Virbac SA | N/A | |
| Habib Ramdani | Virbac SA | 46 | |
| Ekaterina Eliseeva | Bonduelle SCA | N/A | |
Management Performance
| Return On Equity | 0.0308 | |||
| Return On Asset | 0.0137 |
Guerbet S A Leadership Team
Elected by the shareholders, the Guerbet S's board of directors comprises two types of representatives: Guerbet S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guerbet. The board's role is to monitor Guerbet S's management team and ensure that shareholders' interests are well served. Guerbet S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guerbet S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francois Nicolas, RI RD | ||
| Jerome Estampes, CFO Licensing | ||
| Charlotte Bamiere, G Counsel | ||
| Petra Zalabak, Sr Responsibility | ||
| Philippe Bourrinet, Medical Devel | ||
| JeanFrancois Blanc, VP Imaging | ||
| David Hale, MD CEO | ||
| AnneLaure Delasalle, VP Communications | ||
| Valrie Brissart, VP Imaging | ||
| Sarah Dayre, VP Operations |
Guerbet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guerbet S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0308 | |||
| Return On Asset | 0.0137 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 389.73 M | |||
| Shares Outstanding | 12.62 M | |||
| Shares Owned By Insiders | 56.19 % | |||
| Shares Owned By Institutions | 14.39 % | |||
| Price To Earning | 13.97 X | |||
| Price To Book | 0.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Guerbet Stock
Guerbet S financial ratios help investors to determine whether Guerbet Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guerbet with respect to the benefits of owning Guerbet S security.